Protagonist Therapeutics (NASDAQ:PTGX) Now Covered by Analysts at Piper Sandler

Retrieved on: 2020-12-16 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Protagonist Therapeutics (NASDAQ:PTGX) Now Covered by Analysts at Piper Sandler. View article details on hiswai:

Excerpt

<b>AQR Capital Management</b> LLC acquired a new position in shares of Protagonist Therapeutics during the third quarter worth approximately $446,000.

Article found on: www.marketbeat.com

View Original Article